Beijing Hotgen Biotech Co., Ltd.
SHH: 688068.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Changqing Lin
- Employees
- 1,036
- Headquarters
- Beijing, China
- IPO year
- 2019
- Market cap
- CN¥10.4B
- Website
- https://www.hotgen.com.cn
Loading 688068…
Loading profile data…Frequently asked questions about 688068
What does Beijing Hotgen Biotech Co., Ltd. (688068.SS) do?
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection prod...
Where does 688068.SS trade?
Beijing Hotgen Biotech Co., Ltd. (688068.SS) trades on the Shanghai Stock Exchange.
What sector is 688068.SS in?
Beijing Hotgen Biotech Co., Ltd. (688068.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Beijing Hotgen Biotech Co., Ltd.?
Changqing Lin is the chief executive officer of Beijing Hotgen Biotech Co., Ltd. (688068.SS).
Where is Beijing Hotgen Biotech Co., Ltd. headquartered?
Beijing Hotgen Biotech Co., Ltd. is headquartered in China.
Does 688068.SS pay a dividend?
Yes — Beijing Hotgen Biotech Co., Ltd. (688068.SS) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688068.SS go public?
Beijing Hotgen Biotech Co., Ltd. (688068.SS) completed its initial public offering in 2019.